The correlation between the severity of peripheral arterial disease and carotid occlusive disease

Size: px
Start display at page:

Download "The correlation between the severity of peripheral arterial disease and carotid occlusive disease"

Transcription

1 The correlation between the severity of peripheral arterial disease and carotid occlusive disease Tayler H Long a, Michael H Criqui b, Eduard E Vasilevskis c, Julie O Denenberg b, Melville R Klauber b and Arnost Fronek d Abstract: Peripheral arterial disease (PAD) and carotid occlusive disease (COD) are both known to be specific manifestations of atherosclerosis. Because they both have a common cause, it is reasonable to hypothesize that they should correlate with each other to a certain extent, and previous studies have shown that there is a correlation between the prevalence of PAD and COD. The purpose of this study was to determine whether a correlation exists between the severity of PAD and the severity of COD by retrospectively looking at a group of 203 patients who underwent non-invasive testing for suspicion of PAD at the San Diego VA Hospital or UCSD Medical Center, and who also had a non-invasive duplex carotid scan. The severity of PAD was assessed by segmental blood pressure ratios (leg segment/arm ratio) in each leg taken at the toe, ankle, and below the knee, as well as the peak flow velocity of the posterior tibial artery. The severity of COD was assessed by duplex ultrasound scans of six distinct segments of the carotid artery system: the right and left common, internal, and external carotid arteries. Correlation analysis showed r = 0.23 (p = 0.001) when comparing a PAD aggregate standard score with the number of diseased carotid arteries ( 50% stenosis), and r = 0.23 (p = 0.001) when comparing a PAD aggregate standard score with an average COD score. Because about 50% of the patients had undergone surgical intervention on their leg or carotid arteries, another correlation analysis restricted to patients with no surgical interventions (n = 97) was performed. The above correlations were slightly attenuated in this analysis, r = 0.21 (p = 0.043) and r = 0.17 (p = 0.092), respectively. The results indicate that there is a modest but significant correlation between the severity of PAD and the severity of COD in a population with a high prevalence of both. Key words: cardiovascular events; cardiovascular risk factors; carotid artery disease; duplex ultrasonography; non-invasive diagnosis; peripheral arterial disease Introduction The association between manifestations of atherosclerotic cardiovascular disease (CVD) in various arterial beds has been evaluated in numerous studies employing several types of study design. The rationale for expecting a correlation among different arterial beds is the systemic nature of atherosclerosis. Specifically, peripheral arterial disease (PAD) and carotid occlusive disease (COD) have been evaluated to determine how they correlate with each other and with other manifestations of atherosclerosis in several different types of study. These include cross-sectional CVD morbidity studies of symptomatic patients 1,2 ; cross-sectional CVD studies of both symptomatic and asymptomatic patients, with PAD as the reference group 3 9 and with COD as the reference group 6,10 12 ; and CVD prospective morbidity studies with PAD as the reference group, and with COD as the reference group. 16,17 CVD prospective mortality has also been evaluated with PAD as the refera University of Texas, South Western Medical Center, Dallas, TX, b University of California, San Diego, Department of Family & Preventive Medicine, La Jolla, CA, c Oregon Health Sciences University, School of Medicine, Portland, OR, d University of California, San Diego, Department of Surgery and Bio-Engineering, La Jolla, CA, USA Address for correspondence: Michael H Criqui, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA , USA. ence group, 13,18 21 and with COD as the reference group. 17,22 24 These studies in general show a strong correlation between the presence of atherosclerosis in a given arterial bed and the co-prevalence or subsequent development of atherosclerosis in another arterial bed. However, these studies do not address the correlation of the degree of severity of atherosclerosis in two or more arterial beds. There are to our knowledge only two cross-sectional (and no prospective) studies that have directly correlated the severity of two forms of atherosclerosis. An abstract by Wofford et al noted a significant correlation (p ) between COD severity by B-mode ultrasound and CHD stenosis 50% in one or more vessels at angiography. 25 However, the direct correlation between carotid B-mode score and the number of diseased coronary vessels was of only borderline significance (p = 0.10). A second study by Klop et al found a high co-prevalence of COD with PAD, but failed to find a significant correlation between the degree of internal carotid stenosis and PAD severity. 26 These authors evaluated only the internal carotid artery. The goal of our study was to employ a graded definition of PAD and COD in a group of non-invasive vascular laboratory patients and to determine the correlation of the severity of these two conditions. In order to assess the full extent of atherosclerosis more accurately, we assessed PAD by four separate non-invasive tests in each leg and evaluated COD in the internal, external, and common carotid arteries. Arnold X(99)VM289OA

2 136 TH Long et al Methods Study population Between 1990 and 1994, patients seen in the previous 10 years at either the San Diego Veterans Hospital (SDVA) or the University of California, San Diego Medical Center hospital (UCSDMC) vascular laboratories were invited to return for a new, comprehensive, non-invasive vascular examination of the lower extremities as well as an evaluation of their CVD risk factors. In addition, a comprehensive retrospective review of these patients medical records was carried out in order to find all non-invasive duplex examinations of the carotid arteries between 1985 and This report is limited to those patients who had a new, non-invasive lower extremity examination as part of our study between 1990 and 1994 and who had a non-invasive carotid examination between 1985 and The overall population of 508 comprised all subjects studied for PAD during the preceding 15 years who had survived, could be located and were willing to enter the study. This population is representative of vascular laboratory patients who were studied for suspicion of having PAD and remained in the same general geographic location. Of these 508 subjects, 203 had had a carotid duplex examination between 1985 and 1995 and within 5 years of their PAD assessment. This group of 203 is representative of patients who were studied for suspicion of having COD in addition to PAD. Some 72.4% of patients had their PAD and COD examinations within 2 years of each other, 25.0% 2 4 years apart, and 2.6% 4 5 years apart. Non-invasive PAD testing Data were collected on segmental blood pressure ratios (segment/arm) at three levels of the lower extremity (below knee, ankle, and toe). Additionally, peak flow velocity by Doppler ultrasound was measured in the posterior tibial artery (peak PT). In an analysis from a population based study, Feigelson assessed the sensitivity, specificity, positive predictive value, and negative predictive value for each individual segmental blood pressure ratio used in this study as well as the peak flow velocity of the posterior tibial artery. 27 Toe/brachial index (TBI) had a 40.5% sensitivity, 99.4% specificity, 87.8% positive predictive value, and 94.3% negative predictive value. Ankle/brachial index (ABI) had a 39.6% sensitivity, 99.0% specificity, 80.0% positive predictive value, and 94.0% negative predictive value. Below knee/brachial index (BKBI) had a 40.7% sensitivity, 99.4% specificity, 88.1% positive predictive value, and 94.2% negative predictive value. Peak posterior tibial flow had a 70.3% sensitivity, 99.8% specificity, 97.0% positive predictive value, and 97.0% negative predictive value. In addition, Feigelson was able to show that the ABI and peak PT when considered in parallel gave an 89% sensitivity, 99% specificity, 90% positive predictive value, 99% negative predictive value, and 98% overall accuracy for large vessel PAD compared with the entire battery of tests. Feigelson s analysis using ABI and peak PT in parallel only showed the sensitivity, specificity, and predictive values for detecting the presence of disease. Our study was concerned with the severity of PAD. Thus, we used a combination of four non-invasive tests (peak PT, BKBI, ABI, and TBI) that individually had been shown by Feigelson to have good sensitivity, specificity, and predictive values, relative to all the non-invasive tests of the lower extremity, in an attempt to gain a good assessment of the severity of PAD. BKBI, ABI, and TBI Systolic blood pressure was recorded in both arms with a brachial cuff and photoplethysmographic sensor on the third finger of each hand, and the higher of the two pressures was used as the arm pressure. The ratio of arm systolic blood pressure to the systolic pressure recorded by cuffs at the toe, just above the ankle, and just below the knee was recorded by the sphygmomanometric technique and a photoplethysmographic sensor attached to the toe. 28 The photoplethysmographic sensor technique has been shown to produce results identical to Doppler ultrasound for both arm and leg pressures, 29 and has the advantage of allowing simultaneous pressure determination. All toe, ankle, and below knee/brachial indices greater than 1.15 were converted to 1.15 because such values frequently represent stiff walled arteries (e.g. calcified arteries) and do not correlate with the severity of actual stenosis at higher indices. Peak PT The Doppler effect produced by backscattered ultrasound from red blood cells in motion was used to measure flow velocity in the posterior tibial artery. 30 All peak PT measurements above 11 cm/s were converted to 11 cm/s because variability in flow velocities above 10 cm/s does not correlate with actual stenosis (Criqui, unpublished data.) Overall PAD severity Severity was measured along a continuous scale by adding up the standard scores of all eight measurements (four from each leg). Standard scores were calculated by finding the study population s mean and standard deviation for each method of measurement (TBI, ABI, BKBI, and peak PT). Each patient s measurement for each leg was then given a standard score based on how far their measurement deviated from the mean. For example, if a patient had a TBI in their left leg that was 1 standard deviation above the mean for TBI, they were given a score of 1 for that measurement. If they had a right ABI that was 1.5 standard deviations below the mean, they were given a standard score of 1.5 for that measurement. The standard scores of all eight measurements (four from each leg) were then added up to give a composite standard score of PAD severity for each patient. The composite PAD score was then multiplied by 1 in order to create a severity score that corresponded with the COD score such that a low score corresponded to less disease. The range for the PAD leg score was 5.43 to Non-invasive COD testing Data on the carotid arteries was obtained from radiology and vascular laboratory records of each patient from 1985 to 1995 at the SDVA and UCSDMC hospitals. Only patients who had a non-invasive carotid artery evaluation using a duplex scanner were included in the study. In a meta-analysis of several studies on duplex ultrasound, Reed found that the concordance of carotid duplex ultrasound with carotid arteriogram had a sensitivity that ranged from 87.0% to 95.8%, a specificity of 81.8% to 96.6%, a positive

3 Correlation between the severity of PAD and COD 137 predictive value of 86.8% to 98.6%, and negative predictive value of 81.5% to 88.9%. 31 The present study uses noninvasive carotid duplex examinations that were conducted over a period of 10 years, in which a variety of different sonographers and readers evaluated the various patients. The reliability of using data from different sonographers and readers was studied by O Leary et al who found insignificant differences between sonographer and reader evaluations of carotid duplex examinations. 32 The severity of COD was assessed by duplex ultrasound scans of six distinct parts of the carotid artery system, which included the right and left common, internal, and external carotid arteries. Each of the six arteries were scored in one of five categories according to their percentage of diameter stenosis. Information on plaque morphology was not included due to the inconsistent reporting of this information. The five stenosis categories were 0 49%, 50 74%, 75 89%, 90 99%, and total occlusion. These categories were based on standard image and flow criteria for the common, internal, and external carotid arteries. 33,34 Rather than smaller increments, 0 49% was used because the imaging studies did not consistently report stenosis less than 50%. Additionally, a stenosis of less than 50% is generally considered to be not hemodynamically significant. Each of the categories was given a score ranging from 0 to 4, with 0 representing 0 49% and 4 representing total occlusion. The severity of COD was evaluated in two separate ways: (1) the average score of the entire carotid artery system using the 0 to 4 scoring system (range: ); and (2) the total number of the six carotid arteries in each patient with a stenosis greater than 49% (i.e. a score of 1 or greater) (range: 0 6). Previous PAD and COD interventions Questions were asked concerning the type, anatomic locations, and date of previous surgeries and/or angioplasties for PAD and COD. In addition to statistical analysis of the whole study population, patients who had arterial intervention in either the legs or carotids were analyzed separately from patients who had not had previous intervention at the time of the study. Statistics Correlation analyses controlling for age and sex, including those between the severity of PAD and COD, were determined using the Pearson correlation coefficient. Spearman s rank order correlation was used to correlate PAD and COD while controlling for age, sex, HDL cholesterol, exercise, pack-years of cigarettes, systolic blood pressure (SBP), and history of diabetes. A t-test was used to determine if there was a significant difference in the group average for the leg standard score, average carotid score, and number of diseased arteries among each group of patients with and without a history of TIA, stroke, and heart attack. All analyses were conducted using the SAS statistical package. Results Many of the patients had severe cardiovascular disease, often in several systems, and many were disabled. Table 1 Table 1 Comparison of patients with a carotid duplex examination with patients without a carotid duplex examination. Patients with duplex Patients without duplex Ethnicity comparison (n = 203) (n = 303) Caucasian 182 (89.7%) 259 (85.5%) Hispanic 8 (3.9%) 20 (6.6%) African American 7 (3.4%) 16 (5.3%) Native American 4 (2%) 6 (2%) Asian/Pacific Islander 1 (0.5%) 0 (0%) Other 1 (0.5%) 2 (0.7%) Sex (n = 203) (n = 305) Male 189 (93.1%) 259 (84.9%) Female 14 (6.9%) 46 (15.1%) Age (n = 203) (n = 305) Maximum Minimum Mean Education (n = 203) (n = 305) Some high school or less 46 (22.7%) 64 (21.0%) High school graduate 53 (26.1%) 65 (21.3%) Some college or tech school 63 (31.0%) 117 (38.4%) College graduate or more 41 (20.2%) 59 (19.3%) Hospital breakdown (n = 203) (n = 295) UCSDMC 21 (10.4%) 28 (9.5%) SDVA 181 (89.6%) 267 (90.5%) Carotid pulse (n = 203) (n = 305) Maximum 4 4 Minimum Mean Carotid bruit (n = 203) (n = 305) Yes 80 (39.4%) 54 (17.7%) No 123 (60.6%) 251 (82.3%) Carotid surgery (n = 203) (n = 305) Yes 31 (15.3%) 15 (4.9%) No 172 (84.7%) 290 (95.1%) Leg surgery (n = 203) (n = 305) Yes 87 (42.9%) 98 (32.1%) No 116 (57.1%) 207 (67.9%) History of heart attack (n = 201) (n = 302) Yes 69 (34.3%) 87 (28.8%) No 120 (59.7%) 198 (65.6%) Uncertain 12 (6.0%) 17 (5.6%) History of stroke (n = 202) (n = 304) Yes 61 (30.2%) 62 (20.4%) No 135 (66.8%) 232 (76.3%) Uncertain 6 (3.0%) 10 (3.3%) History of TIA (n = 202) (n = 304) Yes 38 (18.8%) 33 (10.9%) No 147 (72.8%) 251 (82.6%) Uncertain 17 (8.4%) 20 (6.6%) compares the 203 patients in the study group with the 305 patients not studied because they had not had a previous carotid duplex examination. The age, sex, ethnicity, education profile and hospital of the study group and non-study group were similar. There was a higher percentage of carotid bruits, vascular surgeries and histories of heart attacks, transient ischemic attacks (TIA), and strokes in the

4 138 TH Long et al study group than in the non-study group, which was expected because the study group had a higher suspicion for diffuse atherosclerotic disease. Overall, the 203 patients used in this study were demographically comparable with the patients who were not included in the study. Table 2 shows that the mean, median, and standard deviation of the PAD standard score for the 203 patients in the study group did not significantly differ from the that of the 305 non-study patients without carotid scans. The PAD standard score of the study patients who did not have a history of vascular surgery had a lower mean and median, demonstrating less severe disease, than the study group as a whole, which was expected because patients who did not have surgery were most likely to have less severe disease. Also, in patients with surgery, disease could recur in the surgically corrected leg, and such patients were more likely to have significant disease in the other leg. The mean, median, and standard deviation of the average carotid score and the number of diseased carotid arteries was similar for the study group as a whole and the subset of patients in the study group who did not have vascular surgery (Table 2). An analysis of our COD scoring system using everyone in the study showed that the average carotid score strongly correlated with the number of diseased carotid arteries (r = 0.90, p ). Figure 1 shows the results of the correlation analysis of all the patients in the study comparing the PAD aggregate standard score with the number of arteries that had greater than 50% stenosis, adjusting for age and sex (n = 193, r = 0.23, p = ). Ten patients were missing complete data on their legs so a PAD standard score could not be generated. Figure 2 shows the same analysis when comparing the average carotid score with the PAD aggregate standard score, adjusting for age and sex (n = 193, r = 0.23, p = ). Table 2 Comparison of patients by PAD standard score and carotid duplex data. Duplex Duplex Patients patients patients without without a duplex history of vascular surgery PAD standard score (n = 193) (n = 97) (n = 288) Maximum Minimum Mean Median Standard deviation Average carotid score (n = 203) (n = 97) Maximum Minimum 0 0 Mean Median Standard deviation No. of diseased carotid (n = 203) (n = 97) arteries Maximum Minimum 0 0 Mean Median Standard deviation About 50% of the patients had some sort of surgical intervention on their carotid or leg arteries that may have confounded the results. Therefore, another correlation analysis was done using patients with no surgical interventions (n = 97). Comparing the PAD aggregate standard score with the number of arteries that had greater than 50% stenosis resulted in an age- and sex-adjusted correlation coefficient of 0.21 (p = 0.043) (Figure 3). Comparing the PAD aggregate standard score with the average carotid score resulted in an age- and sex-adjusted correlation coefficient of 0.17 (p = 0.092) (Figure 4). Additional correlation analyses were done comparing the leg (right or left) with the most severe disease with the side of the carotid system (right or left) with the most severe disease. Perhaps surprisingly, this did not significantly improve the correlation results. The leg with the least severe disease was also correlated with the side of the carotid system with the least severe disease. No significant correlation was found. Correlation analyses were also done between the PAD standard score and the average carotid score, and between PAD and the number of diseased carotid arteries, while adjusting for age, sex, and several known CVD risk factors (HDL, pack-years, exercise, systolic blood pressure, and history of diabetes) (Table 3). These risk factors were included because they had a p 0.20 when correlated independently with PAD and COD. Risk factor adjustment resulted in only minor changes: r = 0.22 (n = 183, p = ) for the PAD aggregate standard score versus the number of diseased carotid arteries and r = 0.21 (n = 183, p = ) for the PAD aggregate standard score versus the average carotid score. For patients with no surgical intervention, the results after risk factor adjustment again only showed minor change: r = 0.21 (n = 90, p = 0.058) for the PAD aggregate standard score versus the number of arteries and r = 0.15 (n = 90, p = 0.18) for the PAD aggregate standard score versus the average carotid score. Table 4 shows the group mean scores for leg standard score, average carotid score, and the number of diseased carotids for each group of patients with and without a history of TIA, stroke, and heart attack. There was a significantly higher group mean average carotid score among patients with a history of TIA (0.55, n= 38) compared with those without a history of TIA (0.35, n = 167) (p = 0.015). The difference in the group mean number of diseased carotids for patients with and without TIA was close to significance (with TIA 1.76, n = 38; without TIA 1.35, n = 167; p = 0.11). The difference in the group mean leg standard score for patients with and without a history of stroke was also close to significance (with stroke 0.54, n = 57; without stroke 0.33, n = 136; p = 0.055). All other PAD and COD score group mean comparisons for clinical events did not reach statistical significance, but all but one (PAD score among patients with or without TIA) were in the expected direction, supportive of the hypothesis that atherosclerosis is a systemic disease. We did separate analyses correlating the PAD standard score with the two types of COD severity scoring among groups of patients with and without a history of TIA, stroke, and heart attack, respectively. For patients with a history of TIA the correlation results were: PAD score versus number of diseased carotids n = 37, r = 0.43,

5 Correlation between the severity of PAD and COD 139 Figure 1 Scattergram of PAD standard score by number of diseased carotid arteries: all patients. Figure 2 Scattergram of PAD standard score by average carotid score: all patients. Figure 3 Scattergram of PAD standard score by number of diseased carotid arteries: patients without surgical intervention.

6 140 TH Long et al Figure 4 Scattergram of PAD standard score by average carotid score: patients without surgical intervention. Table 3 Correlations between PAD standard score and carotid duplex results. All patients in study Adjusted for age and sex Adjusted for age, sex, and risk factors a r p r p PAD standard score versus (n = 193) (n = 183) no. of diseased carotids PAD standard score versus (n = 193) (n = 183) average carotid score Patients with no surgical intervention PAD standard score versus (n = 97) (n = 90) no. of diseased carotids PAD standard score versus (n = 97) (n = 90) average carotid score a Adjusted risk factors include HDL, exercise, pack-years, SBP, and history of diabetes. Table 4 PAD and COD scores in patients with and without histories of transient ischemic attack (TIA), stroke, and myocardial infarction (MI). Histories (mean score) PAD Average No. of standard carotid diseased score score carotids With TIA (n = 37) (n = 38) (n = 38) Without TIA (n = 156) (n = 167) (n = 167) t-statistic p-value With stroke (n = 57) (n = 61) (n = 61) Without stroke (n = 136) (n = 144) (n = 144) t-statistic p-value With MI (n = 65) (n = 69) (n = 69) Without MI (n = 128) (n = 136) (n = 136) t-statistic p-value p = ; PAD score versus average carotid score n = 37, r = 0.49, p = For patients without a history of TIA the correlation results were: PAD score versus number of diseased carotids n = 156, r = 0.19, p = 0.018; PAD score versus average carotid score n = 156, r = 0.16, p = For patients with a history of stroke the correlation results were: PAD score versus number of diseased carotids n = 57, r = 0.25, p = 0.06; PAD score versus average carotid score n = 57, r = 0.30, p = For patients without a history of stroke the correlation results were: PAD score versus number of diseased carotids n = 136, r = 0.22, p = 0.011; PAD score versus average carotid score n = 136, r = 0.17, p = For patients with a history of heart attack the correlation results were: PAD score versus number of diseased carotids n = 65, r = 0.14, p = 0.26; PAD score versus average carotid score n = 65, r = 0.23, p = For patients without a history of heart attack the correlation results were: PAD score versus number of diseased carotids n = 128, r = 0.27, p = ; PAD score versus average carotid score n = 128, r = 0.25, p =

7 Correlation between the severity of PAD and COD 141 Discussion The results of the correlation analysis comparing the severity of PAD with COD show a modest but significant correlation between the two disease processes, which was hypothesized based on the amount of evidence demonstrating an overlap in the prevalence of PAD and COD. 1,2,6 9,11,12 This correlation persisted even when subjects with carotid or leg surgery were excluded from the analysis, though p-values were less significant primarily due to smaller numbers. What is surprising is that the correlation is not as strong as we might have expected considering the perceived notion that atherosclerosis is a systemic disease. This might be due to several potential biases in the study. One potential bias is selective survival, where patients with severe disease died of clinical events related to their disease, and only those with less severe disease survived to be included in the study. This could lead to a more homogenous study population and a weaker correlation between the severity of PAD and COD. The study population is representative of primarily elderly (mean age 68.5 years) Caucasian males living in San Diego who have been evaluated for high suspicion of both PAD and COD at either a VA hospital or a university medical center. This is not a true representation of the community, but it is a population that is at high risk for developing manifestations of atherosclerosis. The homogeneity of the population likely reduced the strength of the correlation because there was less variability in risk factor and disease severity compared with the general population. Therefore, a study looking at the general population might find a stronger correlation between the severity of PAD and COD than was found in this study. Selective survival might also explain the finding that cardiovascular clinical events (TIA, stroke, and heart attack) correlated weakly with the severity of PAD or COD except for TIA and average carotid score (Table 4). Among the 203 patients studied there was a history of TIA in 18.8%, stroke in 30.2%, and heart attack in 34.3% (Table 1). Therefore, the population did not lack clinical events, but the severity of disease did not appear to correlate significantly with such events even though it has been shown to correlate in population studies 13,14 and a clinical study. 1 Another potential bias with this study, which may account for the correlation results, is that non-invasive techniques were used to assess for stenosis as a means of determining disease severity. This may not clearly reflect the systemic nature of atherosclerosis because a patient may have several atherosclerotic plaques throughout an arterial system. In the absence of clinical or hemodynamic evidence of stenosis, such a patient would be considered disease free in our study. A study using angiography, the gold standard in assessing PAD and COD, would be better at assessing true stenosis, but would still not determine the amount of atherosclerotic plaques. An autopsy study would be the best means of determining the systemic extent of atherosclerosis and the correlation of disease severity among the various arterial beds. One final potential bias is that the patients evaluated were not randomly selected from the original population of 508. Instead, only those who had had carotid duplex scans were used because COD data was needed to compare with PAD data. Tables 1 and 2 compare the population used in the study with the population that did not have carotid duplex scans. The two groups were similar in age, ethnicity, education, hospital site, and carotid and leg standard score. Overall, there was more CVD in the study population, which was expected in a group referred for carotid evaluation. While the above biases might reduce the correlation between PAD and COD, we did note that there was a high correlation between the presence of PAD and COD. This is readily apparent from the fact that most of our patients had some disease at their evaluations for PAD and COD and supports the results of many earlier studies. 1,2,6 9,11,12 Therefore, the correlation between disease severity may only be modest, but the correlation between prevalence of disease is significant. One interesting result that contributes to our assessment of correlation between PAD and COD severity is that the correlation was found to be stronger in groups of patients who had a history of TIA or stroke. This suggests that among patients who have COD severe enough to cause clinical symptoms, there is a stronger correlation between PAD and COD than in those who do not have clinical symptoms. This was not apparent when we looked at patients with and without a history of heart attack, suggesting that severity only correlates when the patient has a clinical event that is secondary to the disease being correlated. Thus, among patients with clinical events related to the disease being correlated (COD), the severity correlation was stronger than when looking at asymptomatic patients. The results of the correlation analyses between PAD and COD severity are congruent with the concept of atherosclerosis as a systemic disease, but their limited strength is most likely due to selective survival and the homogeneity of the population. Adjusting for risk factors reduced the correlation slightly, which was as expected because the risk factors contribute to disease severity. Future prospective population studies that look at disease severity and risk factors over time might be useful in eliminating some of these biases, resulting in potentially stronger correlations. Earlier studies have shown a strong association between the prevalence of PAD and COD. 1,2,6 9,11,12 Our study was consistent with these earlier prevalence studies because some disease was found at most of our patients PAD and COD evaluations suggesting that there is a strong correlation between the prevalence of PAD and COD despite a weaker severity correlation. In summary, our study extended previous studies by looking at the correlation between the severity of PAD and COD. Despite the potential biases in this study, we found a modest, but significant, correlation. Acknowledgements The authors would like to thank Ms Linda Sridhar for assistance in the manuscript preparation. This study was supported by NIH Grant HL 42973, NIH-NCRR GCRC Program Grant M01 RR 00827, NIH Summer Short Term Research Grant 5T 35 HL07491, and an American Heart Association, California Affiliate Student Summer Research Fellowship.

8 142 TH Long et al References 1 Aronow WS, Ahn C. Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women 62 years of age. Am J Cardiol 1994; 74: CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: Criqui MH, Denenberg JO, Langer RD, Fronek A. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med 1997; 2: Valentine RJ, Grayburn PA, Eichhorn EJ, Myers SI, Clagett GP. Coronary artery disease is highly prevalent among patients with premature peripheral vascular disease. J Vasc Surg 1994; 19: Hertzer NR, Beven EG, Young JR et al. Coronary artery disease in peripheral vascular patients: a classification of 1000 coronary angiograms and results of surgical management. Ann Surg 1984; 199: Travers AM, Nel CJC, Barry R, Pienaar CW, Filmater B. Atherosclerosis multi-organ involvement the rule rather than the exception. S Afr Med J 1990; 77: Spurk P, Angelkort B, Selt P. Incidence of arteriosclerotic lesions of the carotid arteries in chronic peripheral arterial disease and myocardial infarction. Angiology 1989; 40: Hennerici M, Aulich A, Sandmann W, Freund HJ. The incidence of asymptomatic extracranial arterial disease. Stroke 1981; 12: Turnipseed WD, Berkoff HA, Belzer FO. Postoperative stroke in cardiac and peripheral vascular disease. Ann Surg 1980; 192: Craven TE, Rye JE, Espeland MA et al. Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis: A case control study. Circulation 1990; 82: Burke GL, Evans GW, Riley WA et al. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults: the atherosclerosis risk in communities (ARIC) study. Stroke 1995; 26: Sutton KC, Wolfson SK, Kuller LH. Carotid and lower extremity arterial disease in elderly adults with isolated systolic hypertension. Stroke 1987; 18: Ogren M, Hedblad B, Isacsson S, Janzon L, Jungquist G, Lindell S. Non-invasively detected carotid stenosis and ischaemic heart disease in men with leg arteriosclerosis. Lancet 1993; 342: Criqui MH, Langer RD, Fronek A, Feigelson HS. Coronary disease and stroke in patients with large-vessel peripheral arterial disease. Drugs 1991; 42 (suppl 5): Newman AB, Sutton-Tyrrell K, Vogt MT, Kuller LH. Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. JAMA 1993; 270: Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 1991; 11: Norris JW, Zhu CZ, Bornstein NM, Chambers BR. Vascular risks of asymptomatic carotid stenosis. Stroke 1991; 22: Criqui MH, Langer RD, Fronek F et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992; 326: McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis 1991; 87: Vogt MT, Wolfson SK, Kuller LH. Lower extremity arterial disease and the aging process: a review. J Clin Epidemiol 1992; 45: Dormandy J, Mahir M, Ascady G et al. Fate of the patient with chronic leg ischaemia. J Cardiovasc Surg 1989; 30: Fields WS, Lemak NA. Joint study of extracranial arterial occlusion. IX. Transient ischemic attacks on the carotid territory. JAMA 1976; 235: Moore DJ, Sheehan MP, Kolm P, Russell JB, Sumner DS. Are strokes predictable with noninvasive methods: a five-year follow-up of 303 unoperated patients. J Vasc Surg 1985; 2: Hennerici M, Hulsbomer HB, Hefter H, Lammerts D, Rautenber W. Natural history of asymptomatic extracranial arterial disease: results of a long-term prospective study. Brain 1987; 110: Wofford JL, Kahl FR, Crouse JR. Relationship of extent of carotid atherosclerosis to coronary disease extent. Clin Res 1990; 38: 335A. 26 Klop RBJ, Eikelboom BC, Taks AC. Screening of the internal carotid arteries in patients with peripheral vascular disease by colour-flow duplex scanning. Eur J Vasc Surg 1991; 5: Feigelson HS, Criqui MH, Fronek A, Langer RD, Molgaard CA. Screening for peripheral arterial disease: the sensitivity, specificity, and predictive value of noninvasive tests in a defined population. Am J Epidemiol 1994; 140: Fronek A. Arterial system (evaluation of the lower and upper extremities). In: Fronek A (ed). Noninvasive diagnostics in vascular disease. New York: McGraw-Hill, 1989: Thulesius O. Principles of pressure measurement. In: Bernstein E (ed). Noninvasive diagnostic techniques in vascular disease, third edition. CV Mosby: St Louis, 1985: Fronek A, Coel M, Bernstein EF. Quantitative ultrasonographic studies of lower extremity flow velocities in health and disease. Circulation 1976; 53: Reed JF. Meta-analysis of the reliability of noninvasive carotid studies. Biomed Instrum Technol 1991; 25: O Leary DH, Polak JF, Wolfson SK Jr et al. Use of sonography to evaluate atherosclerosis in the elderly: the cardiovascular health study. Stroke 1991; 22: Harward TRS, Bernstein EF, Fronek A. Continuous-wave versus range-gated pulse Doppler power frequency spectrum analysis in the detection of carotid arterial occlusive disease. Ann Surg 1986; 204: Harward TRS, Bernstein EF, Fronek A. Range-gated pulsed Doppler power frequency spectrum analysis for the diagnosis of carotid arterial occlusive disease. Stroke 1986; 17:

National Clinical Conference 2018 Baltimore, MD

National Clinical Conference 2018 Baltimore, MD National Clinical Conference 2018 Baltimore, MD No relevant financial relationships to disclose Wound Care Referral The patient has been maximized from a vascular standpoint. She has no other options.

More information

The Changing Landscape of Managing Patients with PAD- Update on the Evidence and Practice of Care in Patients with Peripheral Artery Disease

The Changing Landscape of Managing Patients with PAD- Update on the Evidence and Practice of Care in Patients with Peripheral Artery Disease Interventional Cardiology and Cath Labs The Changing Landscape of Managing Patients with PAD- Update on the Evidence and Practice of Care in Patients with Peripheral Artery Disease Manesh R. Patel MD Chief,

More information

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million life insurance

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million life insurance MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS October 17, 2012 AAIM Triennial Conference, San Diego Robert Lund, MD What Is The Risk? 73 year old NS right-handed male applicant for $1

More information

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million Life Insurance

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million Life Insurance MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS October 17, 2012 AAIM Triennial Conference, San Diego Robert Lund, MD What Is The Risk? 73 year old NS right-handed male applicant for $1

More information

The Accuracy of a Volume Plethysmography System as Assessed by Contrast Angiography

The Accuracy of a Volume Plethysmography System as Assessed by Contrast Angiography Research imedpub Journals http://www.imedpub.com/ DOI: 10.21767/2572-5483.100036 Journal of Preventive Medicine The Accuracy of a Volume Plethysmography System as Assessed by Contrast Angiography Andrew

More information

Vascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital

Vascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital Vascular disease. Structural evaluation of vascular disease Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital resistance vessels : arteries

More information

Joshua A. Beckman, MD. Brigham and Women s Hospital

Joshua A. Beckman, MD. Brigham and Women s Hospital Peripheral Vascular Disease: Overview, Peripheral Arterial Obstructive Disease, Carotid Artery Disease, and Renovascular Disease as a Surrogate for Coronary Artery Disease Joshua A. Beckman, MD Brigham

More information

What s New in the Management of Peripheral Arterial Disease

What s New in the Management of Peripheral Arterial Disease What s New in the Management of Peripheral Arterial Disease Sibu P. Saha, MD, MBA Professor of Surgery Chairman, Directors Council Gill Heart Institute University of Kentucky Lexington, KY Disclosure My

More information

Peripheral Arterial Occlusive Disease- The Challenge in patients with diabetes

Peripheral Arterial Occlusive Disease- The Challenge in patients with diabetes Peripheral Arterial Occlusive Disease- The Challenge in patients with diabetes Ashok Handa Reader in Surgery and Consultant Surgeon Nuffield Department of Surgery University of Oxford Introduction Vascular

More information

ORIGINAL CONTRIBUTION. Long-term Risk of Stroke and Other Vascular Events in Patients With Asymptomatic Carotid Artery Stenosis

ORIGINAL CONTRIBUTION. Long-term Risk of Stroke and Other Vascular Events in Patients With Asymptomatic Carotid Artery Stenosis ORIGINAL CONTRIBUTION Long-term Risk of Stroke and Other Vascular Events in Patients With Asymptomatic Carotid Artery Stenosis Zurab G. Nadareishvili, MD, PhD; Peter M. Rothwell, MD, PhD; Vadim Beletsky,

More information

Progression of Peripheral Arterial Disease Predicts Cardiovascular Disease Morbidity and Mortality

Progression of Peripheral Arterial Disease Predicts Cardiovascular Disease Morbidity and Mortality Journal of the American College of Cardiology Vol. 52, No. 21, 2008 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.07.060

More information

7 th Munich Vascular Conference

7 th Munich Vascular Conference 7 th Munich Vascular Conference Secondary prevention of major cardiovascular events in patients with CHD or PAD - What can we learn from EUCLID and COMPASS, evaluating Clopidogrel, Ticagrelor and Univ.-Prof.

More information

JOURNAL OF VASCULAR SURGERY Volume 32, Number 6 McDermott et al 1165 METHODS

JOURNAL OF VASCULAR SURGERY Volume 32, Number 6 McDermott et al 1165 METHODS Lower ankle/brachial index, as calculated by averaging the dorsalis pedis and posterior tibial arterial pressures, and association with leg functioning in peripheral arterial disease Mary McGrae McDermott,

More information

Asian J. Exp. Sci., Vol. 27, No. 1, 2013; 67-72

Asian J. Exp. Sci., Vol. 27, No. 1, 2013; 67-72 Carotid Intima-media Thickness as a Surrogate Marker of Atherosclerosis and its Correlation with Coronary Risk Factors and Angiographic Severity of Coronary Artery Disease. 1 2 Rajeev Gupta and Rajendra

More information

03/30/2016 DISCLOSURES TO OPERATE OR NOT THAT IS THE QUESTION CAROTID INTERVENTION IS INDICATED FOR ASYMPTOMATIC CAROTID OCCLUSIVE DISEASE

03/30/2016 DISCLOSURES TO OPERATE OR NOT THAT IS THE QUESTION CAROTID INTERVENTION IS INDICATED FOR ASYMPTOMATIC CAROTID OCCLUSIVE DISEASE CAROTID INTERVENTION IS INDICATED FOR ASYMPTOMATIC CAROTID OCCLUSIVE DISEASE Elizabeth L. Detschelt, M.D. Allegheny Health Network Vascular and Endovascular Symposium April 2, 2016 DISCLOSURES I have no

More information

ORIGINAL INVESTIGATION. Relevance of Carotid Stenosis Progression as a Predictor of Ischemic Neurological Outcomes

ORIGINAL INVESTIGATION. Relevance of Carotid Stenosis Progression as a Predictor of Ischemic Neurological Outcomes ORIGINAL INVESTIGATION Relevance of Carotid Stenosis Progression as a Predictor of Ischemic Neurological Outcomes Daniel J. Bertges, MD; Visala Muluk, MD; Jeffrey Whittle, MD, MPH; Mary Kelley, MS; David

More information

Early Identification of PAD: Evidence to Refute USPSTF Position on Screening

Early Identification of PAD: Evidence to Refute USPSTF Position on Screening Early Identification of PAD: Evidence to Refute USPSTF Position on Screening Mehdi H. Shishehbor, DO, MPH, PhD Director Endovascular Services Interventional Cardiology & Vascular Medicine Department of

More information

Antiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease. Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.

Antiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease. Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν. Antiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.Κιλκίς Primary CVD Prevention A co-ordinated set of actions,

More information

M. Ögren,* B. Hedblad, G. Engström and L. Janzon

M. Ögren,* B. Hedblad, G. Engström and L. Janzon Eur J Vasc Endovasc Surg 29, 182 189 (2005) doi:10.1016/j.ejvs.2004.11.013, available online at http://www.sciencedirect.com on Prevalence and Prognostic Significance of Asymptomatic Peripheral Arterial

More information

Peripheral arterial disease (PAD) is most commonly a manifestation of systemic atherosclerosis

Peripheral arterial disease (PAD) is most commonly a manifestation of systemic atherosclerosis Peripheral Arterial Disease Identification and Implications Emile R. Mohler III, MD ORIGINAL INVESTIGATION Peripheral arterial disease (PAD) is most commonly a manifestation of systemic atherosclerosis

More information

Pre-and Post Procedure Non-Invasive Evaluation of the Patient with Carotid Disease

Pre-and Post Procedure Non-Invasive Evaluation of the Patient with Carotid Disease Pre-and Post Procedure Non-Invasive Evaluation of the Patient with Carotid Disease Michael R. Jaff, D.O., F.A.C.P., F.A.C.C. Assistant Professor of Medicine Harvard Medical School Director, Vascular Medicine

More information

CLINICAL STUDY. Yasser Khalil, MD; Bertrand Mukete, MD; Michael J. Durkin, MD; June Coccia, MS, RVT; Martin E. Matsumura, MD

CLINICAL STUDY. Yasser Khalil, MD; Bertrand Mukete, MD; Michael J. Durkin, MD; June Coccia, MS, RVT; Martin E. Matsumura, MD 117 CLINICAL STUDY A Comparison of Assessment of Coronary Calcium vs Carotid Intima Media Thickness for Determination of Vascular Age and Adjustment of the Framingham Risk Score Yasser Khalil, MD; Bertrand

More information

ARIC Manuscript Proposal #1233. PC Reviewed: 4_/_10/07 Status: _A Priority: 2_ SC Reviewed: Status: Priority:

ARIC Manuscript Proposal #1233. PC Reviewed: 4_/_10/07 Status: _A Priority: 2_ SC Reviewed: Status: Priority: ARIC Manuscript Proposal #1233 PC Reviewed: 4_/_10/07 Status: _A Priority: 2_ SC Reviewed: Status: Priority: 1.a. Full Title: Subclinical atherosclerosis precedes type 2 diabetes in the ARIC study cohort

More information

Larry Diaz, MD, FSCAI Mehdi H. Shishehbor, DO, FSCAI

Larry Diaz, MD, FSCAI Mehdi H. Shishehbor, DO, FSCAI PAD Diagnosis Larry Diaz, MD, FSCAI Metro Health / University of Michigan Health, Wyoming, MI Mehdi H. Shishehbor, DO, FSCAI University Hospitals Harrington Heart & Vascular Institute, Cleveland, OH PAD:

More information

USWR 23: Outcome Measure: Non Invasive Arterial Assessment of patients with lower extremity wounds or ulcers for determination of healing potential

USWR 23: Outcome Measure: Non Invasive Arterial Assessment of patients with lower extremity wounds or ulcers for determination of healing potential USWR 23: Outcome Measure: Non Invasive Arterial Assessment of patients with lower extremity wounds or ulcers for determination of healing potential MEASURE STEWARD: The US Wound Registry [Note: This measure

More information

Peripheral arterial disease (PAD) is a highly prevalent

Peripheral arterial disease (PAD) is a highly prevalent Exertional Leg Pain in Patients With and Without Peripheral Arterial Disease Jimmy C. Wang, MD; Michael H. Criqui, MD, MPH; Julie O. Denenberg, MA; Mary M. McDermott, MD; Beatrice A. Golomb, MD, PhD; Arnost

More information

Limitation of the resting ankle brachial index in symptomatic patients with peripheral arterial disease

Limitation of the resting ankle brachial index in symptomatic patients with peripheral arterial disease Limitation of the resting ankle brachial index in symptomatic patients with peripheral arterial disease Russell Stein a, Ingrid Hriljac a, Jonathan L Halperin a, Susan M Gustavson a, Victoria Teodorescu

More information

Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease

Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease Cronicon OPEN ACCESS EC NEUROLOGY Research Article Clinical Features and Subtypes of Ischemic Stroke Associated with Peripheral Arterial Disease Jin Ok Kim, Hyung-IL Kim, Jae Guk Kim, Hanna Choi, Sung-Yeon

More information

Imaging for Peripheral Vascular Disease

Imaging for Peripheral Vascular Disease Imaging for Peripheral Vascular Disease James G. Jollis, MD Director, Rex Hospital Cardiovascular Imaging Imaging for Peripheral Vascular Disease 54 year old male with exertional calf pain in his right

More information

Peripheral Arterial Disease Management A Practical Guide for Internists. EFIM Vascular Working Group

Peripheral Arterial Disease Management A Practical Guide for Internists. EFIM Vascular Working Group 2 Peripheral Arterial Disease Management A Practical Guide for Internists EFIM Vascular Working Group 1 Peripheral arterial disease (PAD) is a growing concern among our aging population. More than 27 million

More information

Is there an association between atherosclerosis and chronic venous disease?

Is there an association between atherosclerosis and chronic venous disease? Is there an association between atherosclerosis and chronic venous disease? Karel Roztocil, IKEM, Praha Hungarian Society of Angiology and Vascular Surgery Congress, Szombathely 2017 Disclosure Nothing

More information

Non-invasive examination

Non-invasive examination Non-invasive examination Segmental pressure and Ankle-Brachial Index (ABI) The segmental blood pressure (SBP) examination is a simple, noninvasive method for diagnosing and localizing arterial disease.

More information

Categorical Course: Update of Doppler US 8 : 00 8 : 20

Categorical Course: Update of Doppler US 8 : 00 8 : 20 159 Categorical Course: Update of Doppler US 8 : 00 8 : 20 160 161 Table 1.Comparison of Recommended Values from Data in the Published Literature* S t u d y Lesion PSV E D V VICA/VCCA S e v e r i t y (

More information

Coronary artery disease (CAD) risk factors

Coronary artery disease (CAD) risk factors Background Coronary artery disease (CAD) risk factors CAD Risk factors Hypertension Insulin resistance /diabetes Dyslipidemia Smoking /Obesity Male gender/ Old age Atherosclerosis Arterial stiffness precedes

More information

Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO

Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO Goal of treatment of carotid disease Identify those at risk of developing symptoms Prevent patients at risk from developing symptoms Prevent

More information

Perfusion Assessment in Chronic Wounds

Perfusion Assessment in Chronic Wounds Perfusion Assessment in Chronic Wounds American Society of Podiatric Surgeons Surgical Conference September 22, 2018 Michael Maier, DPM, FACCWS Cardiovascular Medicine Cleveland Clinic Disclosures Speaker,

More information

Clinical Investigation and Reports. Predictive Value of Noninvasive Measures of Atherosclerosis for Incident Myocardial Infarction

Clinical Investigation and Reports. Predictive Value of Noninvasive Measures of Atherosclerosis for Incident Myocardial Infarction Clinical Investigation and Reports Predictive Value of Noninvasive Measures of Atherosclerosis for Incident Myocardial Infarction The Rotterdam Study Irene M. van der Meer, MD, PhD; Michiel L. Bots, MD,

More information

TABLE OF CONTENTS. 2. LOWER EXTREMITY PERIPHERAL ARTERIAL DISEASE 2.1. Epidemiology Risk Factors

TABLE OF CONTENTS. 2. LOWER EXTREMITY PERIPHERAL ARTERIAL DISEASE 2.1. Epidemiology Risk Factors LOWER EXTREMITY PAD The following is one of three extracted sections lower extremity, renal/mesenteric, and abdominal aortic of the ACC/AHA 2005 Guidelines for the Management of Patients With Peripheral

More information

The Multiethnic Study of Atherosclerosis (MESA) Cardiovascular Risk in Hispanics

The Multiethnic Study of Atherosclerosis (MESA) Cardiovascular Risk in Hispanics The Multiethnic Study of Atherosclerosis (MESA) Cardiovascular Risk in Hispanics Michael H. Criqui MD, MPH Distinguished Professor and Chief, Division of Preventive Medicine Department of Family and Preventive

More information

Guidelines for Management of Peripheral Arterial Disease

Guidelines for Management of Peripheral Arterial Disease Guidelines for Management of Peripheral Arterial Disease Subhash Banerjee, MD, FACC, FSCAI Professor of Medicine, Univ. of Texas Southwestern Medical Center Chief, Division of Cardiology, VA North Texas

More information

Disclosures. State of the Art Management of Carotid Stenosis. NIH funding for clinical trials Consultant for Scientia Vascular and Medtronic

Disclosures. State of the Art Management of Carotid Stenosis. NIH funding for clinical trials Consultant for Scientia Vascular and Medtronic State of the Art Management of Carotid Stenosis Mark R. Harrigan, MD UAB Stroke Center Professor of Neurosurgery, Neurology, and Radiology University of Alabama, Birmingham Disclosures NIH funding for

More information

The presenter does not have any potential conflicts of interest to disclose

The presenter does not have any potential conflicts of interest to disclose Carotid intima-media thickness as a predictor of multi territory atherosclerotic occlusive disease in patients with symptomatic subclavian artery obstruction Leszek Wrotniak 1, Anna Kabłak Ziembicka 1,

More information

When to screen for PAD? Prof. Dr.Tine De Backer Prof. Dr. Jean-Claude Wautrecht

When to screen for PAD? Prof. Dr.Tine De Backer Prof. Dr. Jean-Claude Wautrecht When to screen for PAD? Prof. Dr.Tine De Backer Prof. Dr. Jean-Claude Wautrecht How do we define asymptomatic PAD? A. ABI < 1 B. ABI < 0.9 C. ABI < 0.8 D. ABI > 1 How do we define asymptomatic PAD? A.

More information

Abdominal Aortic Doppler Waveform in Patients with Aorto-iliac Disease

Abdominal Aortic Doppler Waveform in Patients with Aorto-iliac Disease Eur J Vasc Endovasc Surg (2010) 39, 714e718 Abdominal Aortic Doppler Waveform in Patients with Aorto-iliac Disease G. Styczynski a, *, C. Szmigielski a, J. Leszczynski b, A. Kuch-Wocial a, M. Szulc a a

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: carotid_intimal_medial_thickness 12/2006 10/2016 10/2018 10/2017 Description of Procedure or Service Ultrasonographic

More information

International Journal of Basic & Applied Physiology

International Journal of Basic & Applied Physiology EARLY DIAGNOSIS OF ASYMPTOMATIC PERIPHERAL ARTERIAL DISEASE BY ANKLE- BRACHIAL PRESSURE INDEX METHOD IN SMOKERS Unmesh S Dave *, Pradnya A Gokhale **, Chinmay J Shah ***, H.B.Mehta ****, Pravin G Rabari

More information

STATINS FOR PAD Long - term prognosis

STATINS FOR PAD Long - term prognosis STATINS FOR PAD Long - term prognosis Prof. Pavel Poredos, MD, PhD Department of Vascular Disease University Medical Centre Ljubljana Slovenia DECLARATION OF CONFLICT OF INTEREST No conflict of interest

More information

Disclosures. Critical Limb Ischemia. Vascular Testing in the CLI Patient. Vascular Testing in Critical Limb Ischemia UCSF Vascular Symposium

Disclosures. Critical Limb Ischemia. Vascular Testing in the CLI Patient. Vascular Testing in Critical Limb Ischemia UCSF Vascular Symposium Disclosures Vascular Testing in the CLI Patient None 2015 UCSF Vascular Symposium Warren Gasper, MD Assistant Professor of Surgery UCSF Division of Vascular Surgery Critical Limb Ischemia Chronic Limb

More information

Guidelines for Ultrasound Surveillance

Guidelines for Ultrasound Surveillance Guidelines for Ultrasound Surveillance Carotid & Lower Extremity by Ian Hamilton, Jr, MD, MBA, RPVI, FACS Corporate Medical Director BlueCross BlueShield of Tennessee guidelines for ultrasound surveillance

More information

Lecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors

Lecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors Lecture 8 Cardiovascular Health 1 Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors 1 Human Health: What s Killing Us? Health in America Health is the U.S Average life

More information

EVALUATION OF CAROTID ARTERY STENOSIS IN STROKE/TRANSIENT ISCHAEMIC ATTACK Nambakam Tanuja Subramanyam 1, Naveen Kumar P 2, Girish P.

EVALUATION OF CAROTID ARTERY STENOSIS IN STROKE/TRANSIENT ISCHAEMIC ATTACK Nambakam Tanuja Subramanyam 1, Naveen Kumar P 2, Girish P. EVALUATION OF CAROTID ARTERY STENOSIS IN STROKE/TRANSIENT ISCHAEMIC ATTACK Nambakam Tanuja Subramanyam 1, Naveen Kumar P 2, Girish P. Vakrani 3 HOW TO CITE THIS ARTICLE: Nambakam Tanuja Subramanyam, Naveen

More information

Asymptomatic Occlusion of an Internal Carotid Artery in a Hospital Population: Determined by Directional Doppler Ophthalmosonometry

Asymptomatic Occlusion of an Internal Carotid Artery in a Hospital Population: Determined by Directional Doppler Ophthalmosonometry Asymptomatic Occlusion of an Internal Carotid Artery in a Hospital Population: Determined by Directional Doppler Ophthalmosonometry BY MARK L. DYKEN, M.D.,* J. FREDERICK DOEPKER, JR., RICHARD KIOVSKY,

More information

Theoretical and practical questions in the evaluation of arterial function Miklós Illyés MD. Ph.D.

Theoretical and practical questions in the evaluation of arterial function Miklós Illyés MD. Ph.D. Theoretical and practical questions in the evaluation of arterial function Miklós Illyés MD. Ph.D. TensioMed Arterial Stiffness Centre, Budapest Heart Institute, Faculty of Medicine, University of Pécs

More information

Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD

Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD Preclinical Detection of CAD: Is it worth the effort? Michael H. Crawford, MD 1 Preclinical? No symptoms No physical findings No diagnostic ECG findings No chest X-ray X findings No diagnostic events 2

More information

Peripheral Arterial Disease Extremity

Peripheral Arterial Disease Extremity Peripheral Arterial Disease Lower Extremity 05 Contributor Dr Steven Chong Advisors Dr Ashish Anil Dr Tay Jam Chin Introduction Risk Factors Clinical Presentation Classification History PHYSICAL examination

More information

Is the Ankle-Brachial Index a Useful Screening Test for Subclinical Atherosclerosis in Asymptomatic, Middle-Aged Adults?

Is the Ankle-Brachial Index a Useful Screening Test for Subclinical Atherosclerosis in Asymptomatic, Middle-Aged Adults? Is the Ankle-Brachial Index a Useful Screening Test for Subclinical Atherosclerosis in Asymptomatic, Middle-Aged Adults? Rachael A. Wyman, MD; Jon G. Keevil, MD; Kjersten L. Busse, RN, MSN; Susan E. Aeschlimann,

More information

PAD Characterization Within A Healthcare System" RAPID Face-to-Face Meeting Schuyler Jones, MD September 14, 2016

PAD Characterization Within A Healthcare System RAPID Face-to-Face Meeting Schuyler Jones, MD September 14, 2016 PAD Characterization Within A Healthcare System" RAPID Face-to-Face Meeting Schuyler, MD September 14, 2016 Interventional Cardiology and Cath Labs Disclosures Research Grants: Agency for Healthcare Research

More information

Ankle brachial pressure index to assess atherosclerotic risk in hypertensive subjects

Ankle brachial pressure index to assess atherosclerotic risk in hypertensive subjects International Journal of Research in Medical Sciences Salagre SB et al. Int J Res Med Sci. 2017 Feb;5(2):403-409 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Original Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20170040

More information

A new era in the treatment of peripheral artery disease (PAD)?

A new era in the treatment of peripheral artery disease (PAD)? A new era in the treatment of peripheral artery disease (PAD)? Prof. Dr. Jan Beyer-Westendorf Head of Thrombosis Research, University Hospital Carl Gustav Carus, TU Dresden; Germany Senior Lecturer Thrombosis

More information

The Struggle to Manage Stroke, Aneurysm and PAD

The Struggle to Manage Stroke, Aneurysm and PAD The Struggle to Manage Stroke, Aneurysm and PAD In this article, Dr. Salvian examines the management of peripheral arterial disease, aortic aneurysmal disease and cerebrovascular disease from symptomatology

More information

ORIGINAL INVESTIGATION. The Long-term Prognostic Value of the Resting and Postexercise Ankle-Brachial Index

ORIGINAL INVESTIGATION. The Long-term Prognostic Value of the Resting and Postexercise Ankle-Brachial Index ORIGINAL INVESTIGATION The Long-term Prognostic Value of the Resting and Postexercise Ankle-Brachial Index Harm H. H. Feringa, MD; Jeroen J. J. Bax, MD, PhD; Virginie H. van Waning, MD; Eric Boersma, PhD;

More information

CLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION

CLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION Donald L. Renfrew, MD Radiology Associates of the Fox Valley, 333 N. Commercial Street, Suite 100, Neenah, WI 54956 6/30/2012 Radiology Quiz of the Week # 79 Page 1 CLINICAL PRESENTATION AND RADIOLOGY

More information

Copyright HMP Communications

Copyright HMP Communications 100-105_VDM0709_Jaffer:CaseStudy.qxd 7/13/09 12:08 PM Page 100 ORIGINAL CONTRIBUTION Comparison of Doppler Ultrasound, Photoplethysmographic, and Pulse-Oximetric Calculated Pressure Indices To Detect Peripheral

More information

The Systolic Hypertension in the Elderly Program

The Systolic Hypertension in the Elderly Program 44 Blood Pressure Treatment Slows the Progression of Carotid Stenosis in Patients With Isolated Systolic Hypertension Kim Sutton-Tyrrell, DrPH; Sidney K. Wolfson, Jr, MD; Lewis H. Kuller, MD Background

More information

Cardiovascular Diseases in CKD

Cardiovascular Diseases in CKD 1 Cardiovascular Diseases in CKD Hung-Chun Chen, MD, PhD. Kaohsiung Medical University Taiwan Society of Nephrology 1 2 High Prevalence of CVD in CKD & ESRD Foley RN et al, AJKD 1998; 32(suppl 3):S112-9

More information

Role of Clopidogrel in Acute Coronary Syndromes. Hossam Kandil,, MD. Professor of Cardiology Cairo University

Role of Clopidogrel in Acute Coronary Syndromes. Hossam Kandil,, MD. Professor of Cardiology Cairo University Role of Clopidogrel in Acute Coronary Syndromes Hossam Kandil,, MD Professor of Cardiology Cairo University ACS Treatment Strategies Reperfusion/Revascularization Therapy Thrombolysis PCI (with/ without

More information

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD Hein J. Verberne Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands International Conference

More information

Imaging Strategy For Claudication

Imaging Strategy For Claudication Who are the Debators? Imaging Strategy For Claudication Duplex Ultrasound Alone is Adequate to Select Patients for Endovascular Intervention - Pro: Dennis Bandyk MD No Disclosures PRO - Vascular Surgeon

More information

ORIGINAL INVESTIGATION. Exertional Leg Symptoms Other Than Intermittent Claudication Are Common in Peripheral Arterial Disease

ORIGINAL INVESTIGATION. Exertional Leg Symptoms Other Than Intermittent Claudication Are Common in Peripheral Arterial Disease ORIGINAL INVESTIGATION Exertional Leg Symptoms Other Than Intermittent Claudication Are Common in Peripheral Arterial Disease Mary McGrae McDermott, MD; Shruti Mehta, BA; Philip Greenland, MD Background:

More information

Carotid Ddisease, Carotid IMT and Risk of Stroke

Carotid Ddisease, Carotid IMT and Risk of Stroke Carotid Ddisease, Carotid IMT and Risk of Stroke TATJANA RUNDEK, MD PhD Professor of Neurology, Epidemiology and Public Health Director, Clinical translational Division Department of Neurology, Miller

More information

Advances in the treatment of posterior cerebral circulation symptomatic disease

Advances in the treatment of posterior cerebral circulation symptomatic disease Advances in the treatment of posterior cerebral circulation symptomatic disease Athanasios D. Giannoukas MD, MSc(Lond.), PhD(Lond.), FEBVS Professor of Vascular Surgery Faculty of Medicine, School of Health

More information

Intima-Media Thickness

Intima-Media Thickness European Society of Cardiology Stockholm, 30th August 2010 Intima-Media Thickness Integration of arterial assessment into clinical practice Prof Arno Schmidt-Trucksäss, MD Institute of Exercise and Health

More information

Thank you for the opportunity to provide expert advice on the Draft Research Plan on Screening for Peripheral Artery Disease.

Thank you for the opportunity to provide expert advice on the Draft Research Plan on Screening for Peripheral Artery Disease. January 12, 2012 Robert L. Cosby, Ph.D., MSW Senior Coordinator, USPSTF Department of Health and Human Services Agency for Healthcare Research and Quality Center for Primary Care, Prevention and Clinical

More information

Case Study: Chris Arden. Peripheral Arterial Disease

Case Study: Chris Arden. Peripheral Arterial Disease Case Study: Chris Arden Peripheral Arterial Disease Patient Presentation Diane is a 65-year-old retired school teacher She complains of left calf pain when walking 50 metres; the pain goes away after she

More information

Peripheral Arterial Disease: Who has it and what to do about it?

Peripheral Arterial Disease: Who has it and what to do about it? Peripheral Arterial Disease: Who has it and what to do about it? Seth Krauss, M.D. Alaska Annual Nurse Practitioner Conference September 16, 2011 Scope of the Problem Incidence: 20%

More information

Carotid Artery Revascularization: Current Strategies. Shonda Banegas, D.O. Vascular Surgery Carondelet Heart and Vascular Institute September 6, 2014

Carotid Artery Revascularization: Current Strategies. Shonda Banegas, D.O. Vascular Surgery Carondelet Heart and Vascular Institute September 6, 2014 Carotid Artery Revascularization: Current Strategies Shonda Banegas, D.O. Vascular Surgery Carondelet Heart and Vascular Institute September 6, 2014 Disclosures None 1 Stroke in 2014 Stroke kills almost

More information

Goals of Screening Programs. What is Vascular Screening? Assumptions Regarding the Potential Benefits of Screening Programs PAD

Goals of Screening Programs. What is Vascular Screening? Assumptions Regarding the Potential Benefits of Screening Programs PAD Conflict of Interest Disclosure (Relationships with Industry) An Epidemic of : The Debate Over Population Screening Membership on an advisory board, consultant, or recipient of a research grant from the

More information

Balancing Efficacy and Safety of P2Y12 Inhibitors for ACS Patients

Balancing Efficacy and Safety of P2Y12 Inhibitors for ACS Patients SYP.CLO-A.16.07.01 Balancing Efficacy and Safety of P2Y12 Inhibitors for ACS Patients dr. Hariadi Hariawan, Sp.PD, Sp.JP (K) TOPICS Efficacy Safety Consideration from Currently Available Antiplatelet Agents

More information

Introduction. Risk factors of PVD 5/8/2017

Introduction. Risk factors of PVD 5/8/2017 PATHOPHYSIOLOGY AND CLINICAL FEATURES OF PERIPHERAL VASCULAR DISEASE Dr. Muhamad Zabidi Ahmad Radiologist and Section Chief, Radiology, Oncology and Nuclear Medicine Section, Advanced Medical and Dental

More information

Gender and Peripheral Arterial Disease

Gender and Peripheral Arterial Disease Gender and Peripheral Arterial Disease Tracie C. Collins, MD, MPH, Maria Suarez-Almazor, MD, PhD, Ruth L. Bush, MD, and Nancy J. Petersen, PhD Objective: The aim of this study is to determine gender differences

More information

ORIGINAL INVESTIGATION

ORIGINAL INVESTIGATION ORIGINAL INVESTIGATION Pulse Oximetry as a Potential Screening Tool for Lower Extremity Arterial Disease in Asymptomatic Patients With Diabetes Mellitus G. Iyer Parameswaran, MD; Kathy Brand, RDMS, RVT;

More information

Ankle-Brachial Index and Subclinical Cardiac and Carotid Disease

Ankle-Brachial Index and Subclinical Cardiac and Carotid Disease American Journal of Epidemiology Copyright ª 2005 by the Johns Hopkins Bloomberg School of Public Health All rights reserved Vol. 162, No. 1 Printed in U.S.A. DOI: 10.1093/aje/kwi167 Ankle-Brachial Index

More information

Imaging Biomarkers: utilisation for the purposes of registration. EMEA-EFPIA Workshop on Biomarkers 15 December 2006

Imaging Biomarkers: utilisation for the purposes of registration. EMEA-EFPIA Workshop on Biomarkers 15 December 2006 Imaging Biomarkers: utilisation for the purposes of registration EMEA-EFPIA Workshop on Biomarkers 15 December 2006 Vascular Imaging Technologies Carotid Ultrasound-IMT IVUS-PAV QCA-% stenosis 2 ICH E

More information

Validation of a method for determination of the ankle-brachial index in the seated position

Validation of a method for determination of the ankle-brachial index in the seated position Validation of a method for determination of the ankle-brachial index in the seated position Heather L. Gornik, MD, MHS, a Bobby Garcia, BA, a Kathy Wolski, MPH, a David C. Jones, BSEE, b Kate A. Macdonald,

More information

FIRST COAST SERVICE OPTIONS FLORIDA MEDICARE PART B LOCAL COVERAGE DETERMINATION

FIRST COAST SERVICE OPTIONS FLORIDA MEDICARE PART B LOCAL COVERAGE DETERMINATION FIRST COAST SERVICE OPTIONS FLORIDA MEDICARE PART B LOCAL COVERAGE DETERMINATION CPT/HCPCS Codes 93875 Non-invasive physiologic studies of extracranial arteries, complete bilateral study (eg, periorbital

More information

V.A. is a 62-year-old male who presents in referral

V.A. is a 62-year-old male who presents in referral , LLC an HMP Communications Holdings Company Clinical Case Update Latest Trends in Critical Limb Ischemia Imaging Amit Srivastava, MD, FACC, FABVM Interventional Cardiologist Bay Area Heart Center St.

More information

Session : Why do stroke patients need a cardiologist? PREVALENCE OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH CEREBRAL INFARCTION

Session : Why do stroke patients need a cardiologist? PREVALENCE OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH CEREBRAL INFARCTION Session : Why do stroke patients need a cardiologist? PREVALENCE OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH CEREBRAL INFARCTION The Asymptomatic Myocardial Ischemia in Stroke and Atherosclerotic Disease

More information

Is there enough evidence for DAPT after endovascular intervention for PAOD?

Is there enough evidence for DAPT after endovascular intervention for PAOD? Is there enough evidence for DAPT after endovascular intervention for PAOD? Prof. I. Baumgartner Head Clinical & Interventional Angiology University Hospital Bern Disclosure Speaker name:...i. Baumgartner...

More information

Objective Calcium score carotid IMT hs-crp

Objective Calcium score carotid IMT hs-crp P3952 Role of coronary calcium score, carotid intima-media thickness and C-reactive protein in predicting extent of coronary artery disease in young patients. Bedside Poster P3952 Role of coronary calcium

More information

Radiologic Evaluation of Peripheral Arterial Disease

Radiologic Evaluation of Peripheral Arterial Disease January 2003 Radiologic Evaluation of Peripheral Arterial Disease Grace Tye, Harvard Medical School Year III Patient D.M. CC: 44 y/o male with pain in his buttocks Occurs after walking 2 blocks. Pain is

More information

Does color-flow imaging improve the accuracy of duplex carotid evaluation?

Does color-flow imaging improve the accuracy of duplex carotid evaluation? Does color-flow imaging improve the accuracy of duplex carotid evaluation? Gregg L. Londrey, MD, Donald P. Spadone, MD, Kim J. Hodgson, MD, Don E. Ramsey, MD, Lynne D. Barkmeier, MD, and David S. Sumner,

More information

CVD risk assessment using risk scores in primary and secondary prevention

CVD risk assessment using risk scores in primary and secondary prevention CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities

More information

Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications

Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications Paul E Norman, John W Eikelboom and Graeme J Hankey Peripheral arterial disease, whether symptomatic

More information

JMSCR Vol 04 Issue 10 Page October 2016

JMSCR Vol 04 Issue 10 Page October 2016 www.jmscr.igmpublication.org Impact Factor 5.244 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v4i10.82 Carotid Intima Media Thickness and Can

More information

Garland Green, MD Interventional Cardiologist. Impact of PAD: Prevalence, Risk Factors, Testing, and Medical Management

Garland Green, MD Interventional Cardiologist. Impact of PAD: Prevalence, Risk Factors, Testing, and Medical Management Garland Green, MD Interventional Cardiologist Impact of PAD: Prevalence, Risk Factors, Testing, and Medical Management Peripheral Arterial Disease Affects over 8 million Americans Affects 12% of the general

More information

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM REVIEW DATE REVIEWER'S ID HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM : DISCHARGE DATE: RECORDS FROM: Hospitalization ER Please check all that may apply: Myocardial Infarction Pages 2, 3,

More information

Slide 1. Slide 2 Conflict of Interest Disclosure. Slide 3 Stroke Facts. The Treatment of Intracranial Stenosis. Disclosure

Slide 1. Slide 2 Conflict of Interest Disclosure. Slide 3 Stroke Facts. The Treatment of Intracranial Stenosis. Disclosure Slide 1 The Treatment of Intracranial Stenosis Helmi Lutsep, MD Vice Chair and Dixon Term Professor, Department of Neurology, Oregon Health & Science University Chief of Neurology, VA Portland Health Care

More information

To provide information on the use of acetyl salicylic acid in the treatment and prevention of vascular events.

To provide information on the use of acetyl salicylic acid in the treatment and prevention of vascular events. ACETYL SALICYLIC ACID TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To provide information on the use of acetyl salicylic acid in the treatment and prevention of vascular events.

More information

9/29/2015. Primary Prevention of Heart Disease: Objectives. Objectives. What works? What doesn t?

9/29/2015. Primary Prevention of Heart Disease: Objectives. Objectives. What works? What doesn t? Primary Prevention of Heart Disease: What works? What doesn t? Samia Mora, MD, MHS Associate Professor, Harvard Medical School Associate Physician, Brigham and Women s Hospital October 2, 2015 Financial

More information